Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources
←Back to briefings
Chorus (CNU) / HY25

Operating profit up 9.9% but PBT collapsed 94.6% on financing costs

Revenue and EBITDA both grew, but a heavier debt load drove PBT to NZ$2m and NPAT to a NZ$5m loss while the dividend was lifted.

Telecommunications & Media / Telecommunications infrastructure

CNU revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY25 was $500m, versus $503m in HY24.

CNU EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
  • HY24 CNU HY: Outside range low ebitda margin. 69%; 3-period range 69.2% to 70.6%. EBITDA margin: 69.0%, below normal range; 3-period mean 70.0%, range 69.2%-70.6%.
EBITDA margin: 69.0%, below normal range; 3-period mean 70.0%, range 69.2%-70.6%.

CNU operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY25 was $257m, versus $243m in HY24.

CNU working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
FY24 was $3m, versus $26m in HY23.

Market context

Valuation

A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.

Prices as at close, 8 June 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$4.1b

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

170.48x

i

Recent market cap compared with trailing earnings.

EPS

0.06

i

Recent filing-derived earnings per share.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

10.15x

i

Enterprise value compared with recent EBITDA.

P/FCF

9.19x

i

Market cap compared with recent free cash flow.

P/B

9.52x

i

Market value compared with latest reported equity.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

6.2%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
24 February 2025
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources

Key metrics

Numbers worth scanning first

HY25 vs HY24

Revenue

$500m

+4.0% ↑ vs $481m

EBITDA

$346m

+5.8% ↑ vs $327m

Net profit after tax

−$5m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net cash inflow from operating activities

$257m

-4.8% ↓ vs $270m

Interim dividend per share

23.0c

+70.4% ↑ vs 13.5c

Profit before tax

$2m

-94.6% ↓ vs $37m

Cash and cash equivalents

$83m

+418.8% ↑ vs $16m

Total assets

$6.1b

+0.7% ↑ vs $6b

What changed

The operating result improved, but everything below operating profit deteriorated sharply

Revenue grew 4.0% to NZ$500.0m, EBITDA rose to NZ$346.0m, and operating profit increased 9.9% to NZ$111.0m. Profit before tax then collapsed 94.6% to NZ$2.0m from NZ$37.0m, and NPAT swung to a NZ$5.0m loss from a NZ$26.0m profit (-119.2%).

The wedge between operating profit and PBT is the financing line. Gross borrowings rose 33.7% to NZ$2.9b and net debt/EBITDA stepped up to 8.1x from 6.6x, so the roughly NZ$10m of operating-profit improvement was more than absorbed by a higher interest charge.

Cash quality moved the other way: capex fell 19.1% to NZ$199.0m and pre-lease free cash flow more than doubled to NZ$58.0m, well above the company's historical baseline mean of -NZ$7.0m (range -NZ$45.0m to NZ$24.0m). The interim dividend was lifted to 23.0 cents from 13.5 cents.

What matters

Financing cost is now the binding constraint on earnings

Operating profit growth of 9.9% was fully consumed below the line, and PBT margin compressed to 0.4%. With net debt/EBITDA at 8.1x and gross borrowings up NZ$727m year-on-year, the operating improvement Chorus is delivering is not currently reaching the bottom line for shareholders.

The tax line distorted the headline NPAT print. The effective tax rate of 350.0% versus 29.7% in the prior period is well above the historical range and turns a small NZ$2.0m PBT into a NZ$5.0m reported loss; PBT is the cleaner read on the period, and PBT itself is weak. This matters because the loss headline overstates the period's deterioration relative to underlying operations, while PBT understates how much of the operating gain is being lost to financing.

Cash generation improved even as earnings fell. Pre-lease FCF of NZ$58.0m sits above the supplied historical range, driven mainly by lower capex (39.8% of revenue versus 51.1%) rather than higher operating cash flow, which actually fell 4.8% to NZ$257.0m. The implication is that current free cash strength is partly a build-cycle effect, not a step-change in earnings power.

Expectations

No forward guidance or stated multi-year target is supplied in the release excerpts, so this can only be judged against shape context

The HY24/FY24 split implies a second-half-weighted year: HY24 contributed 47.6% of FY24 revenue and 46.7% of FY24 EBITDA, and FY24 NPAT was already a NZ$9.0m loss. On that pattern, the HY25 NZ$5.0m loss is consistent with another full-year loss unless interest costs ease or operating leverage from fibre revenue accelerates in the second half.

The release does not support any read on whether financing costs have peaked, which is the variable that matters most for FY25 PBT and dividend coverage.

Quality of result

Operating-line quality looks reasonable: revenue growth of 4.0% is within the company's historical range, EBITDA margin of 69.2% sits at the lower edge of the historical 68.0%–78.9% range, and operating cash flow of NZ$257.0m converts at 74.3% of EBITDA, within the historical range (mean 78.9%) even though it is below the prior comparable's 82.6%

The cash result is balance-sheet-assisted rather than purely earnings-driven. Pre-lease FCF improvement of NZ$34m came predominantly from a NZ$47m capex reduction, not operating cash, so durability depends on whether current capex intensity is a sustained step-down or a timing trough. The dividend lift to 23.0 cents is hard to reconcile with a NZ$5.0m statutory loss and 8.1x leverage; on the prior comparable, the payout ratio versus NPAT was already 106.6%, and the current period cannot be covered from reported earnings at all. ROE moved to -0.8% from 1.8%, a direct read-through of the financing pressure.

Unresolved

Open questions

What is management's expected run-rate finance cost for FY25 and beyond as more debt rolls onto prevailing rates?
Why did gross borrowings rise NZ$727m and total assets NZ$1,600m year-on-year, and how much of this is build-related versus refinancing?
How is the 23.0 cent interim dividend being funded given the NZ$5.0m statutory loss, and what coverage does management consider acceptable?
What capex trajectory underpins the lower 39.8% capex/revenue ratio, and is it sustainable through the fibre completion period?
Is there a stated path to bringing net debt/EBITDA below the 8.1x current level, and over what timeframe?

This briefing cannot assess whether the financing cost step-up reflects rate resets, drawn debt for capex, or both, because the release excerpts supplied do not break out interest expense drivers.

Chat

Ask about CNU HY25

Ask follow-up questions about Chorus's HY25 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about CNU HY25

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Chorus's HY25 result.

What is management's expected run-rate finance cost for FY25 and beyond as more debt rolls onto prevailing rates?Why does "Financing cost is now the binding constraint on earnings" matter?How strong was the cash and earnings quality in HY25?What should I watch next for CNU after HY25?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

1. Chorus media release HY25

HY25 / media release↗

2. Investor Presentation

HY25 / results presentation↗

3. Chorus HY25 Management Commentary and Financial Statements

HY25 / financial report↗

4. HY25 Results Announcement

HY25 / results announcement↗

Prior comparable period

Half year results details: Tuesday 27 February 2024

HY24 / financial report↗

Full-year context

Annual Report - FY24

FY24 / financial report↗

Media Release - FY24 results

FY24 / media release↗

NZX Financial Results Announcement - FY24

FY24 / results announcement↗

Release context

Chorus investor day – speaker details and webcast link

HY25 / commentary↗

Chorus Investor Day 2024 - cover

HY25 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Leverage and balance-sheet risk

Net debt / EBITDA is 8.10x, +1.50x versus the prior comparable period.

→

Cash conversion quality

This result converted 74.3% of EBITDA to operating cash flow, -8.3pp versus the prior comparable period.

→

Earnings quality and statutory distortions

This result includes a statutory earnings-quality distortion flag.

→

Revenue growth context

Revenue growth was 4.0% for this reporting period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when CNU publishes next

Get the next Chorus briefing and related NZX reporting-season updates by email.